Overview

Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

Status:
Completed

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to review the local management of patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia treated with vancomycin or linezolid with the goal to define if any difference exists among these antimicrobials in regard to clinical and economic outcomes.

Details

Lead Sponsor:

Pfizer

Collaborators:

Henry Ford Hospital
Jackson Health System
Sparrow Health System
Summa Health System
University of Louisville

Treatments:

Linezolid
Vancomycin